Bone Biologics Corp Stock Price History

BBLG Stock  USD 1.92  0.12  6.67%   
Below is the normalized historical share price chart for Bone Biologics Corp extending back to March 31, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bone Biologics stands at 1.92, as last reported on the 13th of May 2024, with the highest price reaching 1.97 and the lowest price hitting 1.77 during the day.
IPO Date
31st of March 2016
200 Day MA
4.2006
50 Day MA
1.97
Beta
0.626
 
Yuan Drop
 
Covid
If you're considering investing in Bone Stock, it is important to understand the factors that can impact its price. Bone Biologics Corp secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12% return per unit of risk over the last 3 months. Bone Biologics Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bone Biologics' Mean Deviation of 4.95, risk adjusted performance of (0.02), and Standard Deviation of 7.61 to double-check the risk estimate we provide.
  
The Bone Biologics' current Total Stockholder Equity is estimated to increase to about 3.1 M, while Common Stock Shares Outstanding is projected to decrease to roughly 250 K. . At this time, Bone Biologics' Price Fair Value is most likely to increase significantly in the upcoming years. Bone Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1218

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBBLG

Estimated Market Risk

 6.3
  actual daily
55
55% of assets are less volatile

Expected Return

 -0.77
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.12
  actual daily
0
Most of other assets perform better
Based on monthly moving average Bone Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bone Biologics by adding Bone Biologics to a well-diversified portfolio.
Price Book
0.5075
Book Value
5.44
Enterprise Value
-2 M
Enterprise Value Ebitda
0.1646
Shares Float
480.9 K

Bone Biologics Stock Price History Chart

There are several ways to analyze Bone Stock price data. The simplest method is using a basic Bone candlestick price chart, which shows Bone Biologics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 20, 20243.9
Lowest PriceApril 25, 20241.52

Bone Biologics May 13, 2024 Stock Price Synopsis

Various analyses of Bone Biologics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Bone Stock. It can be used to describe the percentage change in the price of Bone Biologics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Bone Stock.
Bone Biologics Price Daily Balance Of Power 0.60 
Bone Biologics Price Rate Of Daily Change 1.07 
Bone Biologics Price Action Indicator 0.11 

Bone Biologics May 13, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Bone Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Bone Biologics intraday prices and daily technical indicators to check the level of noise trading in Bone Stock and then apply it to test your longer-term investment strategies against Bone.

Bone Stock Price History Data

The price series of Bone Biologics for the period between Tue, Feb 13, 2024 and Mon, May 13, 2024 has a statistical range of 2.63 with a coefficient of variation of 30.82. The prices are distributed with arithmetic mean of 2.3. The median price for the last 90 days is 2.2. The company had 1:8 stock split on 20th of December 2023. Bone Biologics Corp issued dividends on 2018-07-24.
OpenHighLowCloseVolume
05/13/2024
 1.80  1.97  1.77  1.92 
05/10/2024 1.80  1.97  1.77  1.92  43,098 
05/09/2024 1.80  1.82  1.78  1.80  21,106 
05/08/2024 1.71  1.83  1.65  1.81  8,781 
05/07/2024 1.83  1.83  1.70  1.76  33,747 
05/06/2024 1.80  1.90  1.76  1.83  19,976 
05/03/2024 1.90  1.94  1.80  1.85  25,218 
05/02/2024 1.66  2.02  1.66  1.85  128,210 
05/01/2024 1.58  1.69  1.55  1.68  19,233 
04/30/2024 1.63  1.63  1.55  1.56  4,027 
04/29/2024 1.55  1.64  1.55  1.57  19,930 
04/26/2024 1.53  1.61  1.51  1.53  28,507 
04/25/2024 1.50  1.58  1.47  1.52  15,177 
04/24/2024 1.58  1.61  1.46  1.53  60,392 
04/23/2024 1.58  1.65  1.57  1.60  26,532 
04/22/2024 1.70  1.75  1.60  1.60  20,809 
04/19/2024 1.82  1.94  1.61  1.61  77,302 
04/18/2024 1.74  1.94  1.67  1.80  92,964 
04/17/2024 1.73  1.77  1.61  1.77  19,435 
04/16/2024 1.73  1.77  1.56  1.75  42,834 
04/15/2024 1.62  1.78  1.61  1.61  19,506 
04/12/2024 1.64  1.76  1.64  1.68  18,740 
04/11/2024 1.68  1.70  1.62  1.67  27,637 
04/10/2024 1.69  1.70  1.63  1.64  28,553 
04/09/2024 1.75  1.78  1.65  1.70  23,431 
04/08/2024 1.80  1.86  1.70  1.78  19,040 
04/05/2024 1.84  1.87  1.65  1.73  97,381 
04/04/2024 1.96  2.05  1.76  1.79  90,582 
04/03/2024 2.01  2.13  1.87  1.96  31,870 
04/02/2024 2.27  2.28  1.96  2.00  49,242 
04/01/2024 2.17  2.26  2.10  2.13  11,515 
03/28/2024 2.04  2.26  2.02  2.13  21,288 
03/27/2024 2.08  2.23  2.03  2.04  16,162 
03/26/2024 2.19  2.19  2.08  2.10  12,685 
03/25/2024 2.22  2.25  2.12  2.22  16,089 
03/22/2024 2.21  2.30  2.10  2.25  18,438 
03/21/2024 2.25  2.39  2.14  2.20  19,644 
03/20/2024 2.33  2.34  2.22  2.29  11,315 
03/19/2024 2.29  2.46  2.22  2.40  35,134 
03/18/2024 2.41  2.50  2.22  2.22  22,408 
03/15/2024 2.49  2.56  2.30  2.33  13,216 
03/14/2024 2.50  2.60  2.40  2.49  34,628 
03/13/2024 2.45  2.73  2.40  2.57  121,328 
03/12/2024 2.51  2.57  2.30  2.41  74,734 
03/11/2024 2.46  2.56  2.33  2.56  46,845 
03/08/2024 2.33  2.47  2.30  2.41  23,428 
03/07/2024 2.23  2.40  2.22  2.34  44,236 
03/06/2024 2.38  2.43  2.30  2.34  50,115 
03/05/2024 2.35  2.46  2.21  2.29  65,692 
03/04/2024 2.52  2.77  2.35  2.47  656,761 
03/01/2024 2.89  3.09  2.20  2.43  1,872,892 
02/29/2024 2.51  2.56  2.40  2.45  36,548 
02/28/2024 2.32  2.58  2.26  2.31  34,411 
02/27/2024 2.71  2.71  2.30  2.36  91,938 
02/26/2024 3.34  3.37  2.54  2.70  208,552 
02/23/2024 3.60  3.69  3.25  3.60  22,326 
02/22/2024 3.25  4.49  3.25  3.60  83,873 
02/21/2024 3.72  4.00  3.15  3.15  44,133 
02/20/2024 3.85  4.09  3.65  3.90  15,921 
02/16/2024 3.76  4.05  3.60  3.88  13,181 
02/15/2024 3.95  4.21  3.56  3.85  25,503 

About Bone Biologics Stock history

Bone Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bone is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bone Biologics Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bone Biologics stock prices may prove useful in developing a viable investing in Bone Biologics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding263.1 K250 K
Net Loss-1.9 M-1.9 M

Bone Biologics Stock Technical Analysis

Bone Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bone Biologics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bone Biologics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Bone Biologics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Bone Biologics' price direction in advance. Along with the technical and fundamental analysis of Bone Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bone to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Bone Biologics Corp is a strong investment it is important to analyze Bone Biologics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bone Biologics' future performance. For an informed investment choice regarding Bone Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bone Biologics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Bone Stock analysis

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Bone Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(34.01)
Return On Assets
(0.96)
Return On Equity
(2.02)
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.